DYNATRONICS CORP - FORM 10-Q - February 11, 2020

Attached files

file filename
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - DYNATRONICS CORPexh32-2.htm
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - DYNATRONICS CORPexh32-1.htm
EX-31.2 - CERTIFICATION UNDER RULE 13A-14(A)/15D-14(A) OF PRINCIPAL FINANCIAL OFFICER AND - DYNATRONICS CORPexh31-2.htm
EX-31 - CERTIFICATION UNDER RULE 13A-14(A)/15D-14(A) OF PRINCIPAL EXECUTIVE OFFICER - DYNATRONICS CORPexh31-1.htm
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended December 31, 2019
 
or
 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _________ to _________
 
Commission File Number: 0-12697
 
Dynatronics Corporation
(Exact name of registrant as specified in its charter)
 
 
Utah
87-0398434
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
7030 Park Centre Drive, Cottonwood Heights, Utah 84121
(Address of principal executive offices, Zip Code)
 
(801) 568-7000
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading symbol
Name of each exchange on which registered
Common Stock, no par value per share
DYNT
Nasdaq Capital Market
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ☐ No
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑Yes ☐ No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
 
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☑
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
 
As of February 6, 2020, there were 9,949,775 shares of the registrant’s common stock outstanding.
 

 
 
 
DYNATRONICS CORPORATION
FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2019
TABLE OF CONTENTS
 
 
 
 
 
 
Page
 
 
 
 
 
  1 
 
    
  1 
 
    
  2 
 
    
  3

    
 4
 
    
 5
 
    
 10
 
    
 10
 
    
 13
 
    
 14
 
    
 
    
 14

  
   14

  
   14

  
   14

  
   14

  
   14

  
 14
 
    
 15
 
 
 
  
PART I. FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
 
DYNATRONICS CORPORATION
 
 
Condensed Consolidated Balance Sheets
 
 
(Unaudited)
 
 
 
 
 
 
 
 
 Assets
 
December 31, 2019
 
 
June 30, 2019
 
     Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 $431,485 
 $155,520 
Restricted cash
  100,510 
  100,510 
Trade accounts receivable, less allowance for doubtful accounts of $89,500 as of December 31, 2019 and June 30, 2019
  6,940,398 
  7,495,309 
Other receivables
  50,928 
  2,776 
Inventories, net
  11,383,968 
  11,527,521 
Prepaid expenses
  741,705 
  632,061 
 
    
    
          Total current assets
  19,648,994 
  19,913,697 
 
    
    
Property and equipment, net
  5,369,236 
  5,677,419 
Operating lease assets
  3,311,497 
  - 
Intangible assets, net
  6,045,183 
  6,407,374 
Goodwill
  7,116,614 
  7,116,614 
Other assets
  505,502 
  516,841 
 
    
    
          Total assets
 $41,997,026 
 $39,631,945 
 
    
    
Liabilities and Stockholders' Equity
    
    
     Current liabilities:
    
    
Accounts payable
 $5,970,178 
 $3,989,546 
Accrued payroll and benefits expense
  1,111,523 
  1,373,481 
Accrued expenses
  758,422 
  1,038,726 
Warranty reserve
  207,988 
  207,988 
Line of credit
  4,819,106 
  6,540,639 
Current portion of long-term debt
  175,615 
  173,921 
Current portion of finance lease liability
  303,849 
  283,781 
Current portion of deferred gain
  150,448 
  150,448 
Current portion of operating lease liability
  898,849 
  - 
Acquisition earn-out liability
  - 
  500,000 
Income tax payable
  2,401 
  16,751 
 
    
    
          Total current liabilities
  14,398,379 
  14,275,281 
 
    
    
Long-term debt, net of current portion
  38,503 
  129,428 
Finance lease liability, net of current portion
  2,752,480 
  2,915,241 
Deferred gain, net of current portion
  1,303,882 
  1,379,105 
Operating lease liability, net of current portion
  2,412,649 
  - 
Other liabilities
  186,218 
  177,181 
 
    
    
          Total liabilities
  21,092,111 
  18,876,236 
Commitments and contingencies
    
    
 
    
    
     Stockholders' equity:
    
    
Preferred stock, no par value: Authorized 50,000,000 shares; 4,139,000 shares and 4,899,000 shares issued and outstanding as of December 31, 2019 and June 30, 2019, respectively
  9,850,496 
  11,641,816 
Common stock, no par value: Authorized 100,000,000 shares; 9,609,928 shares and 8,417,793 shares issued and outstanding as of December 31, 2019 and June 30, 2019, respectively
  23,668,610 
  21,320,106 
Accumulated deficit
  (12,614,191)
  (12,206,213)
 
    
    
          Total stockholders' equity
  20,904,915 
  20,755,709 
 
    
    
          Total liabilities and stockholders' equity
 $41,997,026 
 $39,631,945 
 
    
    
See accompanying notes to condensed consolidated financial statements.
    
    
 

 
 
1
 
 
 
DYNATRONICS CORPORATION
 
 
Condensed Consolidated Statements of Operations
 
 
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
December 31,
 
 
December 31,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 $15,196,991 
 $15,439,966 
 $31,586,540 
 $32,505,801 
Cost of sales
  10,611,135 
  10,760,093 
  21,846,677 
  22,278,704 
Gross profit
  4,585,856 
  4,679,873 
  9,739,863 
  10,227,097 
 
    
    
    
    
Selling, general, and administrative expenses
  4,618,100 
  4,772,678 
  9,542,792 
  10,269,300 
Operating (loss) income
  (32,244)
  (92,805)
  197,071 
  (42,203)
 
    
    
    
    
Other income (expense):
    
    
    
    
   Interest expense, net
  (110,289)
  (141,788)
  (241,281)
  (262,630)
   Other income, net
  4,870 
  (2,288)
  5,385 
  383,553 
Net other (expense) income
  (105,419)
  (144,076)
  (235,896)
  120,923 
 
    
    
    
    
(Loss) income before income taxes
  (137,663)
  (236,881)
  (38,825)
  78,720 
 
    
    
    
    
Income tax (provision) benefit
  - 
  (203,949)
  - 
  (203,949)
 
    
    
    
    
Net loss
  (137,663)
  (440,830)
  (38,825)
  (125,229)
 
    
    
    
    
Deemed dividend on convertible preferred stock and accretion of discount
  (108,539)
  - 
  (108,539)
  - 
Preferred stock dividend, in common stock, issued or to be issued
  (202,249)
  (203,268)
  (369,153)
  (389,905)
 
    
    
    
    
Net loss attributable to common stockholders
 $(448,451)
 $(644,098)
 $(516,517)
 $(515,134)
 
    
    
    
    
Net loss per common share
    
    
    
    
Basic and diluted
 $(0.05)
 $(0.08)
 $(0.06)
 $(0.06)
 
    
    
    
    
Weighted-average common shares outstanding:
    
    
    
    
Basic and diluted
  9,023,406 
  8,193,324 
  8,800,184 
  8,176,877 
 
    
    
    
    
 
See accompanying notes to condensed consolidated financial statements.
 
    
    
    
 

 
2
 
 
 
DYNATRONICS CORPORATION
 
 
Condensed Consolidated Statements of Stockholders' Equity
 
 
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Total
 
 
 
 Common stock
 
 
   Preferred stock        
 
 
 Accumulated
 
 
 stockholders'
 
 
 
 Shares
 
 
 Amount
 
 
 Shares
 
 
 Amount
 
 
 deficit
 
 
 equity
 
Balance at June 30, 2018
  8,089,398 
 $20,225,107 
  4,899,000 
 $11,641,816 
 $(10,490,141)
 $21,376,782 
 
    
    
    
    
    
    
Stock-based compensation
  5,000 
  43,658 
  - 
  - 
  - 
  43,658 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  66,631 
  186,637 
  - 
  - 
  (186,637)
  - 
 
    
    
    
    
    
    
Net income
  - 
  - 
  - 
  - 
  315,601 
  315,601 
 
    
    
    
    
    
    
Balance at September 30, 2018
  8,161,029 
  20,455,402 
  4,899,000 
  11,641,816 
  (10,361,177)
  21,736,041 
 
    
    
    
    
    
    
Stock-based compensation
  - 
  56,082 
  - 
  - 
  - 
  56,082 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  65,494 
  203,268 
  - 
  - 
  (203,268)
  - 
 
    
    
    
    
    
    
Reduction in equity retained for acquisition holdback
  (37,708)
  - 
  - 
  - 
  - 
  - 
 
    
    
    
    
    
    
Net loss
  - 
  - 
  - 
  - 
  (440,830)
  (440,830)
 
    
    
    
    
    
    
Balance at December 31, 2018
  8,188,815 
  20,714,752 
  4,899,000 
  11,641,816 
  (11,005,275)
  21,351,293 
 
    
    
    
    
    
    
Stock-based compensation
  58,998 
  85,566 
  - 
  - 
  - 
  85,566 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  74,731 
  196,240 
  - 
  - 
  (196,240)
  - 
 
    
    
    
    
    
    
Net loss
  - 
  - 
  - 
  - 
  (563,387)
  (563,387)
 
    
    
    
    
    
    
Balance at March 31, 2019
  8,322,544 
 $20,996,558 
  4,899,000 
 $11,641,816 
 $(11,764,902)
 $20,873,472 
 
    
    
    
    
    
    
Stock-based compensation
  - 
  115,343 
  - 
  - 
  - 
  115,343 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  95,249 
  208,205 
  - 
  - 
  (208,205)
  - 
 
    
    
    
    
    
    
Net loss
  - 
  - 
  - 
  - 
  (233,106)
  (233,106)
 
    
    
    
    
    
    
Balance at June 30, 2019
  8,417,793 
 $21,320,106 
  4,899,000 
 $11,641,816 
 $(12,206,213)
 $20,755,709 
 
    
    
    
    
    
    
Stock-based compensation
  135,244 
  129,793 
  - 
  - 
  - 
  129,793 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  126,194 
  166,904 
  - 
  - 
  (166,904)
  - 
 
    
    
    
    
    
    
Net income
  - 
  - 
  - 
  - 
  98,838 
  98,838 
 
    
    
    
    
    
    
Balance at September 30, 2019
  8,679,231 
 $21,616,803 
  4,899,000 
 $11,641,816 
 $(12,274,279)
 $20,984,340 
 
    
    
    
    
    
    
Stock-based compensation
  5,446 
  58,238 
  - 
  - 
  - 
  58,238 
 
    
    
    
    
    
    
Preferred stock converted to common stock
  760,000 
  1,791,320 
  (760,000)
  (1,791,320)
  - 
  - 
 
    
    
    
    
    
    
Preferred stock dividend, in common stock, issued or to be issued
  165,251 
  202,249 
  - 
  - 
  (202,249)
  - 
 
    
    
    
    
    
    
Net loss
  - 
  - 
  - 
  - 
  (137,663)
  (137,663)
 
    
    
    
    
    
    
Balance at December 31, 2019
  9,609,928 
 $23,668,610 
  4,139,000 
 $9,850,496 
 $(12,614,191)
 $20,904,915 
 
    
    
    
    
    
    
 
See accompanying notes to condensed consolidated financial statements.
 
    
    
    
    
    
 
 
 
3
 
 
 
DYNATRONICS CORPORATION
 
 
Condensed Consolidated Statements of Cash Flows
 
 
(Unaudited)
 
 
 
 
 
 
 
Six Months Ended
 
 
 
December 31,
 
 
 
2019
 
 
2018
 
Cash flows from operating activities:
 
 
 
 
 
 
       Net loss
 $(38,825)
 $(125,229)
       Adjustments to reconcile net loss to net cash provided by operating activities:
    
    
             Depreciation and amortization of property and equipment
  495,000 
  418,289 
             Amortization of intangible assets
  362,191 
  362,192 
             Amortization of other assets
  20,064 
  21,074 
             Loss on sale of property and equipment
  - 
  1,813 
             Stock-based compensation expense
  188,031 
  99,740 
             Change in allowance for doubtful accounts receivable
  - 
  (178,800)
             Change in allowance for inventory obsolescence
  (13,532)
  (35,147)
             Amortization deferred gain on sale/leaseback
  (75,223)
  (75,224)
             Deferred income taxes
  - 
  203,949 
             Change in fair value of earn-out liability
  - 
  (375,000)
             Change in operating assets and liabilities:
    
    
                  Trade accounts receivable and other receivables
  506,759 
  1,109,182 
                  Inventories
  157,085 
  348,392 
                  Prepaid expenses
  (109,644)
  247,630 
                  Other assets
  (8,725)
  (12,483)
                  Income tax receivable
  (14,350)
  (768)
                  Accounts payable and accrued expenses
  1,447,408 
  (881,881)
 
    
    
                              Net cash provided by operating activities
  2,916,239 
  1,127,729 
 
    
    
Cash flows from investing activities:
    
    
       Purchase of property and equipment
  (183,731)
  (52,463)
 
    
    
                              Net cash used in investing activities
  (183,731)
  (52,463)
 
    
    
Cash flows from financing activities:
    
    
       Principal payments on long-term debt
  (89,231)
  (83,049)
       Principal payments on finance lease liability
  (145,779)
  (114,283)
       Payment of acquisition earn-out liability and holdbacks
  (500,000)
  (912,845)
       Net change in line of credit
  (1,721,533)
  (1,137,681)
 
    
    
                              Net cash used in financing activities
  (2,456,543)
  (2,247,858)
 
    
    
                              Net change in cash and cash equivalents and restricted cash
  275,965 
  (1,172,592)
 
    
    
Cash and cash equivalents and restricted cash at beginning of the period
  256,030 
  1,696,116 
 
    
    
Cash and cash equivalents and restricted cash at end of the period
 $531,995 
 $523,524 
 
    
    
Supplemental disclosure of cash flow information:
    
    
       Cash paid for interest
 $256,262 
 $265,251 
Supplemental disclosure of non-cash investing and financing activities:
    
    
       Deemed dividend on convertible preferred stock and accretion of discount
  108,539 
  - 
       Preferred stock dividend, in common stock, issued or to be issued
  369,153 
  389,905 
       Inventory reclassified to demonstration equipment
  - 
  239,106 
       Finance lease obligations incurred to obtain ROU assets
  3,086 
  - 
   Operating lease obligations incurred to obtain ROU assets
  3,749,809  
    - 
   Conversion of preferred stock to common stock
  1,791,320  
  - 
 
    
    
See accompanying notes to condensed consolidated financial statements.
    
    
 

 
4
 
 
DYNATRONICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
December 31, 2019
 
 
Note 1. Presentation and Summary of Significant Accounting Policies
 
Business

Dynatronics Corporation (“Company,” “Dynatronics”) is a leading medical device company committed to providing high-quality restorative products designed to accelerate optimal health. The Company designs, manufactures, and sells a broad range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers.
 
Basis of Presentation
 
The accompanying unaudited condensed consolidated balance sheets as of December 31, 2019, and June 30, 2019, condensed consolidated statements of operations and stockholders'equity for the three and six months ended December 31, 2019 and 2018, and condensed consolidated statements cash flows (“Financial Statements”) of Dynatronics for the six months ended December 31, 2019 and 2018, should be read in conjunction with the audited financial statements and notes thereto as of and for the year ended June 30, 2019 included in the Company’s Annual Report on Form 10-K (“Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on September 25, 2019. In the opinion of management, the accompanying Financial Statements have been prepared by the Company in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of the Company's management, the Financial Statements reflect all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state our financial position, results of operations, and cash flows. The June 30, 2019 condensed consolidated balance sheet was derived from audited financial statements, but does not include all GAAP disclosures. The results of operations for the first six months of the fiscal year are not necessarily indicative of results for the full year or any future periods.
 
The preparation of these unaudited condensed consolidated financial statements requires our management to make estimates and judgments that affect the amounts reported in the financial statements and the accompanying notes. The Company’s actual results may differ from these estimates under different assumptions or conditions.
 
Reclassification
 
Certain amounts in the prior year's Financial Statements have been reclassified for comparative purposes to conform to the presentation in the current year's Financial Statements.
 
Recent Accounting Pronouncements
 
In February 2016, the Financial Accounting Standards Board issued ASU No. 2016-02, Leases ("Topic 842"). This guidance replaces the prior lease accounting guidance in its entirety. The underlying principle of the new standard is the recognition of right-of-use ("ROU") assets and lease liabilities by lessees for substantially all leases. The standard also requires additional quantitative and qualitative disclosures. The Company adopted Topic 842 as of July 1, 2019 using a modified retrospective method. Under this method, financial results reported in periods prior to July 1, 2019 are unchanged. The Company elected the ‘package of practical expedients’ which permits the Company to carryforward the historical lease classification. Adoption of the standard resulted in the recording of additional ROU assets and lease liabilities for operating leases of $3,749,809 as of July 1, 2019. The adoption of this guidance did not have an impact on net loss.
 
 5
 
 
Note 2. Acquisitions
 
Bird & Cronin
 
The earn-out liability was reduced to $0 as of December 31, 2019, after making payments totaling $375,000 during the three months ended December 31, 2019 and $125,000 during the three months ended September 30, 2019.
 
Note 3. Net loss per Common Share
 
Net loss per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options, convertible preferred stock and warrants are considered to be potential common stock. The computation of diluted net loss per common share does not assume exercise or conversion of securities that would have an anti-dilutive effect.
 
Basic net loss per common share is the amount of net income for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted net loss per common share is the amount of net loss for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect.
 
All outstanding options, warrants and convertible preferred stock for common shares are not included in the computation of diluted net loss per common share because they are anti-dilutive, which for the three months ended December 31, 2019, and 2018, totaled 11,607,954 and  11,884,803, respectively, and for the six months ended December 31, 2019, and 2018, totaled 11,685,597 and  11,884,803, respectively.
 
Note 4. Convertible Preferred Stock and Common Stock Warrants
 
As of December 31, 2019, the Company had issued and outstanding a total of 2,000,000 shares of Series A 8% Convertible Preferred Stock (“Series A Preferred”) and 1,459,000 shares of Series B 8% Convertible Preferred Stock ("Series B Preferred"). The Series A Preferred and Series B Preferred are convertible into a total of 3,459,000 shares of common stock. Dividends payable on these preferred shares accrue at the rate of 8% per year and are payable quarterly in stock or cash at the option of the Company. The Company generally pays the dividends on the preferred stock by issuing shares of our common stock. The formula for paying these dividends using common stock in lieu of cash can change the effective yield on the dividend to more or less than 8% depending on the market price of the common stock at the time of issuance. As of December 31, 2019, there were also issued and outstanding 680,000 shares of Series C Non-Voting Convertible Preferred Stock (“Series C Preferred”). The Series C Preferred shares are non-voting, do not receive dividends, and have no liquidation preferences or redemption rights. During the quarter ended December 31, 2019, the Company issued 760,000 shares of commons stock upon conversion of 760,000 shares of Series C Preferred.
 
Note 5. Comprehensive Income
 
For the three and six months ended December 31, 2019 and 2018, comprehensive loss was equal to the net loss as presented in the accompanying condensed consolidated statements of operations.
 
Note 6. Inventories
 
Inventories consisted of the following:
 
 
 
December 31, 2019
 
 
June 30, 2019
 
Raw materials
 $5,805,374
 
 $5,830,140
Work in process
 681,322
 
 706,128
Finished goods
 5,063,534
 
 5,129,806
Inventory obsolescence reserve
  (166,262)
  (138,553)
 
 $11,383,968
 
 $11,527,521
 
 
 6
 
 
Note 7. Leases
 
Management determines if a contract is or contains a lease at inception or modification of a contract. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. Control over the use of the identified asset means the lessee has both (a) the right to obtain substantially all of the economic benefits from the use of the asset and (b) the right to direct the use of the asset. Such assets are classified as ROU assets with a corresponding lease liability.
 
Finance and operating lease ROU assets and liabilities are recorded at commencement at the present value of future minimum lease payments over the expected lease term. As the implicit discount rate for the present value calculation is not determinable in most of the Company’s leases, management uses the Company’s incremental borrowing rate based on the information available at commencement of the lease. The expected lease terms include options to extend the lease when it is reasonably certain the Company will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. Leases with an expected term of 12 months or less are not accounted for on the balance sheet and the related lease expense is recognized on a straight-line basis over the expected lease term.
 
The Company has operating and finance leases for various administrative, manufacturing, and distribution facilities and equipment. Most of the Company’s leases include one or more options to renew and extend the lease term two years to five years. The exercise of lease renewal options is typically at the Company's sole discretion, however, as a material economic incentive to exercise the option exists, the majority of renewals to extend the lease terms are included in the ROU assets and lease liabilities as they are reasonably certain of exercise. The Company’s lease agreements do not contain any material nonlease components, residual value guarantees, or material restrictive covenants.
 
Leases recorded on the balance sheet consist of the following:
 
Classification on the Balance Sheet
 
December 31, 2019
 
Lease Assets
 
 
 
 
Operating lease assets
Operating lease assets
 $3,311,497
Finance lease assets
Property and equipment, net
 $2,711,066
 
    
Lease Liabilities
 
    
Current
 
    
Operating
Current portion of operating lease liability
 $898,849
Finance
Current portion of finance lease liability
 $303,849
Noncurrent
 
    
Operating
Operating lease liability, net of current portion
 $2,412,649
Finance
Finance lease liability, net of current portion
 $2,752,480
 
Other information related to lease term and discount rate is as follows:
 
 
 
December 31, 2019
 
Weighted Average Remaining Lease Term
 
 
 
Operating leases
 
3.5 years
 
Finance leases
 
9.1 years
 
 
 
 
 
Weighted Average Discount Rate
 
 
 
Operating leases
 4.6%
Finance leases
 5.8%
 
 7
 
  
The components of lease expense are as follows:
 
 
Classification on the Statement of Operations
 
Three Months Ended
December 31, 2019
 
 
Six Months Ended
December 31, 2019
 
Operating lease cost
 
 
 
 
 
 
 
Operating lease cost
Cost of sales
 $70,515 
 $141,030 
Operating lease cost
Selling, general, and administrative expenses
  188,531 
  375,932 
Short term lease cost
Selling, general, and administrative expenses
  15,750 
  31,500 
 
    
    
Finance lease cost
 
    
    
Amortization of finance lease assets
Cost of sales
 $35,670 
 $71,340 
Amortization of finance lease assets
Selling, general, and administrative expenses
  49,098 
  97,955 
Interest on finance lease liabilities
Interest expense, net
  45,222 
  90,089 
Total lease cost
 
 $404,786 
 $807,846 

Supplemental cash flow information related to leases is as follows:
 
 
 
Three Months Ended
December 31, 2019
 
 
Six Months Ended
December 31, 2019
 
ROU assets obtained in exchange for lease liabilities:
 
 
 
 
 
 
Operating leases
  - 
  3,749,809 
Financing leases
  - 
  3,086 
 
Future minimum lease payments are summarized as follows:
 
 
 
Operating Leases
 
 
Finance Leases
 
Year ending June 30,
 
 
 
 
 
 
2020 (excluding the six months ended December 31, 2019)
 $515,832
 $227,500
2021
 959,721
  462,286 
2022
 150,000
  469,536 
2023
  - 
  443,056 
2024
  - 
  384,754 
Thereafter
  - 
  2,113,348 
Total future minimum lease payments
 $1,625,553
 $4,100,480
 
    
    
Imputed interest
    
 857,933
Deferred rent
    
 186,218
 
The Company leases office, manufacturing and warehouse facilities in Northvale, New Jersey; and Eagan, Minnesota from employees, shareholders, and entities controlled by shareholders, who were previously principals of businesses acquired by the Company. The combined expenses associated with these related-party transactions totaled $261,666 and $261,780 for the three months ended December 31, 2019 and 2018, respectively, and $523,332 and $523,560 for the six months ended December 31, 2019 and 2018, respectively.
 

 8
 
  
Note 8. Line of Credit
 
The Company has a line of credit (“Line of Credit”) available pursuant to a loan and security agreement (the “Loan and Security Agreement”), as amended, with Bank of the West, that matures on January 15, 2022. The Company’s obligations under the Line of Credit are secured by a first-priority security interest in substantially all of the Company’s assets. The Line of Credit requires a lockbox arrangement and contains affirmative and negative covenants, including covenants that restrict the Company's ability to, among other things, incur or guarantee indebtedness, incur liens, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, make changes in the nature of its business, and engage in transactions with affiliates. The agreement also contains financial covenants including a minimum monthly consolidated fixed charge coverage ratio which only applies when the excess availability amount under the Line of Credit is less than the greater of $1,000,000 or 10% of the borrowing base. As amended, the Loan and Security Agreement provides for revolving credit borrowings in an amount up to the lesser of $11,000,000 or the calculated borrowing base. The borrowing base is computed monthly and is equal to the sum of stated percentages of eligible accounts receivable and inventory, less a reserve. Amounts outstanding bear interest at LIBOR plus 2.25% (approximately 4% as of December 31, 2019). The Line of Credit is subject to an unused line fee of .25%.
 
On January 22, 2020, the Company entered into a Sixth Modification of the Loan and Security Agreement which extended the maturity date of the Line of Credit to January 15, 2022.
  
Borrowings on the Line of Credit were $4,819,106 and $ 6,540,639 as of December 31, 2019 and June 30, 2019, respectively. As of December 31, 2019, there was approximately $2,350,000 available to borrow.
 
Note 9. Accrued Payroll and Benefits Expense
 
As of December 31, 2019 and June 30, 2019, the accrued payroll and benefits expense balance included $153,308 and $310,903, respectively, of accrued severance expense. The Company recognized $75,319 and $27,196 in severance expense during the three months ended December 31, 2019 and 2018, respectively and $153,087 and $131,053 in severance expense during the six months ended December 31, 2019 and 2018, respectively. Severance expense is included in selling, general, and administrative expenses.
 
Note 10.  Revenue
 
As of December 31, 2019 and June 30, 2019, the rebate liability was $321,116 and $287,430, respectively. The rebate liability is included in accrued expenses in the accompanying condensed consolidated balance sheets.
 
As of December 31, 2019 and June 30, 2019, the allowance for sales discounts was $14,500. The allowance for sales discounts is included in trade accounts receivable, less allowance for doubtful accounts in the accompanying condensed consolidated balance sheets.
 
The following table disaggregates revenue by major product category for the three and six months ended December 31:
 
 
 
Three Months Ended
December 31
 
 
Six Months Ended
December 31  
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
Orthopedic Soft Bracing Products
 $   5,833,972
 $5,799,711
 $12,112,998
 $11,671,879
Physical Therapy and Rehabilitation Products
 9,283,017
 9,558,772
 19,320,737
 20,603,613
Other
 80,002
 81,483
 152,805
 230,309
 
 $15,196,991
 $15,439,966
 $31,586,540
 $32,505,801
 
 
Note 11. Subsequent Events
 
In January 2020, the Company paid approximately $202,000 of preferred stock dividends with respect to the Series A Preferred and Series B Preferred that accrued during the three months ended December 31, 2019, by issuing 243,652 shares of common stock.
 
 9
 
 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This report, including the disclosures contained in Part I. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation, contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements include, but are not limited to: any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements can be identified by their use of such words as “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” or “anticipate” and similar references to future periods. 
 
We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry that are subject to risks and uncertainties. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Forward-looking statements are subject to substantial risks and uncertainties that could cause our future business, financial condition, results of operations or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this report. Some of the risks and uncertainties that may cause actual results to differ from those expressed or implied in the forward-looking statements are described in the section “Risk Factors” included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2019, filed with the SEC, as well as in our other public filings with the SEC. Actual results may differ as a result of additional risks and uncertainties of which we are currently unaware or which we do not currently view as material to our business.
 
You should read this report in its entirety, together with the documents that we file as exhibits to this report and the documents that we incorporate by reference into this report, with the understanding that our future results may be materially different from what we currently expect. The forward-looking statements contained in this report are made as of the date of this report and we assume no obligation to update them after the date hereof to revise or conform such statements to actual results or to changes in our opinions or expectations. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.
 
We qualify all of our forward-looking statements by these cautionary statements.
 
The terms “we,” “us,” “Dynatronics,” or the “Company” refer collectively to Dynatronics Corporation and its wholly-owned subsidiaries, unless otherwise stated. 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our Unaudited Condensed Consolidated Financial Statements and Notes thereto that are contained in this quarterly report, with a narrative from the perspective of management. You should also consider this information with the information included in our Annual Report on Form 10-K for the year ended June 30, 2019, and our other filings with the SEC, including our quarterly and current reports that we have filed since June 30, 2019 through the date of this report. In the following MD&A, we have rounded many numbers to the nearest one thousand dollars. These numbers should be read as approximate. All inter-company transactions have been eliminated. Our fiscal year ends on June 30. For example, reference to fiscal year 2020 refers to the year ending June 30, 2020. This report covers the three and six months ended December 31, 2019. Results of operations for the three and six months ended December 31, 2019 are not necessarily indicative of the results that may be achieved for the full fiscal year ending June 30, 2020. 
 
Overview
 
Dynatronics designs, manufactures, and sells a broad range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through our distribution channels, we market and sell to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers.
 
 10
 
 
Results of Operations

 Net Sales
 
Net sales decreased $243,000, or 1.6%, to $15,197,000 for the quarter ended December 31, 2019, compared to net sales of $15,440,000 for the quarter ended December 31, 2018. The year-over-year decrease in net sales was driven by a reduction in sales of physical therapy and rehabilitation products.
 
Net sales decreased $919,000, or 2.8%, to $31,587,000 for the six months ended December 31, 2019, compared to net sales of $32,506,000 for the six months ended December 31, 2018. The year-over-year decrease in net sales was driven by a reduction in sales of physical therapy and rehabilitation products.
 
Gross Profit
 
Gross profit for the quarter ended December 31, 2019 decreased $94,000, or about 2.0%, to $4,586,000, or 30.2% of net sales. By comparison, gross profit for the quarter ended December 31, 2018 was $4,680,000, or 30.3% of net sales. The year-over-year decrease in gross profit was attributable to lower sales of physical therapy and rehabilitation products, which accounted for approximately $74,000 in lower gross profit, and by reduced gross margin percent which accounted for approximately $20,000 in lower gross profit. The year-over-year decrease in gross margin percentage to 30.2% from 30.3% was due primarily to lower sales of our physical therapy and rehabilitation equipment.
 
Gross profit for the six months ended December 31, 2019 decreased $487,000, or about 4.8%, to $9,740,000, or 30.8% of net sales. By comparison, gross profit for the six months ended December 31, 2018 was $10,227,000, or 31.5% of net sales. The year-over-year decrease in gross profit was attributable to lower sales of physical therapy and rehabilitation products, which accounted for approximately $289,000 in lower gross profit, and by reduced gross margin percent which accounted for approximately $198,000 in lower gross profit. The year-over-year decrease in gross margin percentage to 30.8% from 31.5% was due primarily to lower sales of our physical therapy and rehabilitation equipment.
 
 
Selling, General and Administrative Expenses
 
Selling, general and administrative (“SG&A”) expenses decreased $155,000, or 3.2%, to $4,618,000 for the quarter ended December 31, 2019, compared to $4,773,000 for the quarter ended December 31, 2018. The decrease in SG&A is primarily related to a $197,000 decrease in selling expenses due primarily to lower commission expense on lower sales and lower sales management salaries during the quarter.

SG&A expenses decreased $727,000, or 7.1%, to $9,543,000 for the six months ended December 31, 2019, compared to $10,269,000 for the six months ended December 31, 2018. Selling expenses represented $500,000 of the decrease in SG&A expenses due primarily to lower commission expense on lower sales and lower sales management salaries during the six month period. General and administrative (“G&A”) expenses represented $227,000 of the decrease in SG&A expenses. The decrease in G&A is primarily related to a reduction in salaries and wages.
 
Net (Loss) Income Before Income Tax
 
Pre-tax loss for the quarter ended December 31, 2019 was $138,000 compared to $237,000 for the quarter ended December 31, 2018. The $99,000 improvement in pre-tax loss was attributable to the impact of $94,000 decrease in gross profit, offset by (1) $38,000 decrease in other expense primarily due to the $31,000 decrease in interest expense as a result of a decrease in the average balance of our line of credit and related interest rate and (2) $155,000 decrease in SG&A expenses.
 
Pre-tax loss for the six months ended December 31, 2019 was $39,000 compared to pre-tax income of $79,000 for the six months ended December 31, 2018. The $118,000 decline in pre-tax income was attributable to the impact of (1) $358,000 decrease in other income primarily due to a $375,000 change in the fair value of the earn-out liability related to the Bird and Cronin acquisition and (2) $487,000 decrease in gross profit partially offset by a $727,000 decrease in SG&A expenses. 
 
Income Tax Provision
 
Income tax provision was $0 for the three and six months ended December 31, 2019, respectively, compared to $204,000 for the three and six months ended December 31, 2018, respectively. See Liquidity and Capital Resources - Deferred Income Tax Assets below for more information. 
 
Net Loss
 
Net loss was $138,000 for the quarter ended December 31, 2019, compared to $441,000 for the quarter ended December 31, 2018. Net loss was $38,000 for the six months ended December 31, 2019, compared to $125,000 for the six months ended December 31, 2018. The reasons for the changes in net loss are the same as explained above under the heading Net (Loss) Income Before Income Tax and Income Tax Provision.
 
 11
 
 
Net Loss Attributable to Common Stockholders
 
Net loss attributable to common stockholders improved $196,000 to $448,000 for the quarter ended December 31, 2019, compared to $644,000 for the quarter ended December 31, 2018. The improvement in net loss attributable to common stockholders for the quarter is due primarily to a $303,000 improvement in net loss partially offset by a $109,000 increase in deemed dividend on convertible preferred stock and accretion of discount as a result of the conversion of preferred stock. On a per share basis, net loss attributable to common stockholders was $(0.05) per share for the quarter ended December 31, 2019, compared to $(0.08) per share for the quarter ended December 31, 2018.
 
Net loss attributable to common stockholders increased $2,000 to $517,000 for the six months ended December 31, 2019, compared to $515,000 for the six months ended December 31, 2018. The increase in net loss attributable to common stockholders is due primarily to a $109,000 increase in deemed dividend on convertible preferred stock and accretion of discount as a result of the conversion of preferred stock partially offset by a $86,000 decrease in net loss and $21,000 decrease in convertible preferred stock dividend. On a per share basis, net loss attributable to common stockholders was $(0.06) per share for the six months ended December 31, 2019 and 2018, respectively. 
 
Liquidity and Capital Resources
 
We have historically financed operations through cash from operating activities, available cash reserves, borrowings under a line of credit facility (see, Line of Credit, below) and proceeds from the sale of our equity securities. During the quarter ended December 31, 2019, we had positive cash flows from operating activities. We believe that our cash generated from operations, current capital resources, and available credit provide sufficient liquidity to fund operations for the next 12 months.
 
Working capital was $5,251,000 as of December 31, 2019, compared to working capital of $5,638,000 as of June 30, 2019. The current ratio was 1.4 to 1 as of December 31, 2019 and 1.4 to 1 as of June 30, 2019.
 
Cash and Cash Equivalents
 
Our cash and cash equivalents and restricted cash position increased $276,000 to $532,000 as of December 31, 2019, compared to $256,000 as of June 30, 2019. The primary source of cash in the six months ended December 31, 2019, was approximately $2,916,000 of net cash provided by operating activities.
 
Accounts Receivable
 
Trade accounts receivable, net of allowance for doubtful accounts, decreased approximately $555,000, or 7.4%, to $6,940,000 as of December 31, 2019, from $7,495,000 as of June 30, 2019. The decrease was driven primarily by a decrease in sales and the time to collect receivables. Trade accounts receivable represents amounts due from our customers including dealers and distributors that purchase our products for redistribution, medical practitioners, clinics, hospitals, colleges, universities and sports teams. We believe that our estimate of the allowance for doubtful accounts is adequate based on our historical experience and relationships with our customers. Accounts receivable are generally collected within approximately 40 days of invoicing.
 
Inventories
 
Inventories, net of reserves, decreased $144,000 or 1.2%, to $11,384,000 as of December 31, 2019, compared to $11,528,000 as of June 30, 2019. Inventory levels fluctuate based on timing of large inventory purchases from domestic and overseas suppliers as well as variations in sales and production activities. We believe that our allowance for inventory obsolescence is adequate based on our analysis of inventory, sales trends, and historical experience.
 
Accounts Payable
 
Accounts payable increased approximately $1,981,000 or 49.6%, to $5,970,000 as of December 31, 2019, from $3,990,000 as of June 30, 2019. The increase was driven primarily by the timing of international purchases, improved payment terms with primary suppliers, and an increase in the average time to pay suppliers.
 
Line of Credit
 
Our line of credit balance decreased $1,722,000 to $4,819,000 as of December 31, 2019, compared to $6,541,000 as of June 30, 2019. The decrease was driven primarily by positive cash flows from operating activities used to pay down the line of credit. As of December 31, 2019, there was approximately $2,350,000 available to borrow.
 
 12
 
 
Debt
 
  Long-term debt decreased approximately $89,000 to approximately $214,000 as of December 31, 2019, compared to approximately $303,000 as of June 30, 2019. Our long-term debt is primarily comprised of the mortgage loan on our office and manufacturing facility in Tennessee maturing in 2021, and also includes loans related to equipment and a vehicle. The principal balance on the mortgage loan is approximately $166,000, of which $52,000 is classified as long-term debt, with monthly principal and interest payments of $13,000.
 
  Finance Lease Liability
 
Finance lease liability as of December 31, 2019 and June 30, 2019 totaled approximately $3,056,000 and $3,199,000, respectively. Our finance lease liability consists primarily of our Utah building lease. In conjunction with the sale and leaseback of our Utah building in August 2014, we entered into a 15-year lease, classified as a finance lease, originally valued at $3,800,000. The building lease asset is amortized on a straight-line basis over 15 years at approximately $252,000 per year. Total accumulated amortization related to the leased building is approximately $1,365,000 at December 31, 2019. The sale generated a profit of $2,300,000, which is being recognized straight-line over the life of the lease at approximately $150,000 per year as an offset to amortization expense. The balance of the deferred gain as of December 31, 2019 is $1,454,000. Lease payments, currently approximately $27,000, are payable monthly and increase annually by approximately 2% per year over the life of the lease. Imputed interest for the three and six months ended December 31, 2019 was approximately $40,000 and $79,000, respectively. In addition to the Utah building, we have certain equipment leases that we have determined are finance leases.
 
Operating Lease Liability
 
  Operating lease liability as of December 31, 2019 and June 30, 2019 totaled approximately $3,311,000 and $0, respectively. The operating lease liability was recorded upon the adoption of ASU No. 2016-02, Leases. Our operating lease liability consists primarily of building leases for office, manufacturing, warehouse and storage space.
  
Acquisition Earn-Out Liability
 
Acquisition earn-out liability decreased $500,000 or 100.0%, to $0 as of December 31, 2019, from $500,000 as of June 30, 2019. The decrease is due to payment in full of the obligations during the six months ended December 31, 2019. 
 
Deferred Income Tax Assets
 
A valuation allowance is required when there is significant uncertainty as to the realizability of deferred income tax assets. The ability to realize deferred income tax assets is dependent upon our ability to generate sufficient taxable income within the carryforward periods provided for in the tax law for each tax jurisdiction. We have determined that we do not meet the “more likely than not” threshold that deferred income tax assets will be realized. Accordingly, a valuation allowance is required. Any reversal of the valuation allowance in future periods will favorably impact our results of operations in the period of reversal. As of December 31, 2019 and June 30, 2019, we recorded a full valuation allowance against our net deferred income tax assets. This resulted in no reported income tax expense associated with the operating profit reported during the three and six months ended December 31, 2019. As a result of a temporary book to tax difference associated with the amortization of goodwill for tax purposes, income tax expense was $204,000 for the three and six months ended December 31, 2018.
 
Stock Repurchase Plans
 
We have a stock repurchase plan available to us at the discretion of the Board of Directors. Approximately $449,000 remained of this authorization as of December 31, 2019. No purchases have been made under this plan since September 2011.
 
Off-Balance Sheet Arrangements
 
As of December 31, 2019, we had no off-balance sheet arrangements.
 
Critical Accounting Policies
 
The preparation of our financial statements requires that we make estimates and judgments. We base these on historical experience and on other assumptions that we believe to be reasonable. Our critical accounting policies are discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Form 10-K for the year ended June 30, 2019. There have been no material changes to the critical accounting policies previously disclosed in that report.
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk
 
There have been no material changes from the information presented for the year ended June 30, 2019.
 
 13
 
 
Item 4. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
We maintain disclosure controls and procedures that are designed to ensure that information that is required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods that are specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding any required disclosure. In designing and evaluating these disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
 
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act) as of December 31, 2019. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2019.
 
Changes in Internal Control over Financial Reporting
 
There were no changes in our internal control over financial reporting during the quarter ended December 31, 2019, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
PART II. OTHER INFORMATION
 
Item 1. Legal Proceedings
 
None.
 
Item 1A.
 
The risk factors described in our Annual Report on Form 10-K for the year ended June 30, 2019 have not materially changed, except as noted below.
 
We face risks related to health epidemics and other widespread outbreaks of contagious disease, which could significantly disrupt our supply chain and impact our operating results. Significant outbreaks of contagious diseases, and other adverse public health developments, could have a material impact on our business operations and operating results. In December 2019, a strain of novel coronavirus causing respiratory illness emerged in the city of Wuhan in the Hubei province of China. The Chinese government has taken certain emergency measures to combat the spread of the virus, including extension of the Lunar New Year holidays, implementation of travel bans and closure of factories and businesses. Some of our materials and products are sourced from suppliers located in China. While the full impact of this outbreak is unknown at this time, we are closely monitoring the developments in China and continually assessing the potential impact on our business. Any prolonged disruption to our suppliers could negatively impact our sales and operating results.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
 
None.
 
Item 3. Defaults Upon Senior Securities
 
None.
 
Item 4. Mine Safety Disclosures
 
None.
 
Item 5. Other Information
 
None.
 
Item 6. Exhibits
 
(a) Exhibits
 
 
10.1 
 
 
31.1
 
 
31.2
 
 
32.1
 
 
               32.2
 
 
101.INS
XBRL Instance Document
 
 
101.CAL
XBRL Taxonomy Extension Schema Document
 
 
101.SCH
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 14
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
DYNATRONICS CORPORATION
 
 
 
 
 
Date: February 11, 2020
By:
/s/ Brian D. Baker
 
 
 
Brian D. Baker
 
 
 
President and Chief Executive Officer (Principal Executive Officer)
 
 
 
 
 
 
 
 
 
Date: February 11, 2020
By:
/s/ David A. Wirthlin
 
 
 
David A. Wirthlin
 
 
 
Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
  15

Stock widget

Investing forum

DYNATRONICS CORP Reports